Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma ...

In a life-or-death situation, every second matters. Sentara Health is testing a new tool through a pilot program designed to get blood products to patients faster. Haemonetics BloodTrack Systems ...

In the latest quarter, 5 analysts provided ratings for Haemonetics HAE, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings ...

Haemonetics (HAE) announced updates to its Executive Leadership team. Frank Chan, Ph.D. will join Haemonetics as Executive Vice President, COO on April 7, and Roy Galvin has been appointed as the ...

Needham analyst Mike Matson lowered the firm’s price target on Haemonetics (HAE) to $104 from $108 and keeps a Buy rating on the shares. The ...

Haemonetics (HAE) came out with quarterly earnings of $1.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $1.04 per share a year ago. These figures are ...

BOSTON, March 3, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...

Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors ...